Literature DB >> 7405336

[Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].

H Pehamberger, S A Esca, K Holubar.   

Abstract

Treatment with an oral aromatic all-trans retinoid (Ro 10-9359) resulted in clearing of the skin lesions in five patients with ichthyosis, four patients with Darier's disease and one patient with linear porokeratosis. No response to treatment was achieved in two patients with disseminated superficial actinic porokeratosis. Known side effects of retinoid treatment occurred in all patients in different intensity but disappeared when treatment was discontinued. Due to side effects (pruritus) treatment had to be discontinued only in one patient with Darier's disease and preexisting diabetes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7405336

Source DB:  PubMed          Journal:  Z Hautkr        ISSN: 0301-0481


  2 in total

Review 1.  Etretinate therapy in children with severe keratinization defects.

Authors:  H Traupe; R Happle
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

Review 2.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.